Active Funded Projects

Updated October 15, 2021
Data provided by University at Buffalo Sponsored Projects Services
Additional information on each funded project is also included where possible

Award Principal Investigator Award Name Award Type Sponsor Name Award Start Date Award End Date Total Cost
Balthasar, Dr. Joseph Catch and Release Immunotoxins: CAR-Bombs for Cancer Federal National Cancer Institute 07-Dec-2016 30-Nov-2021 1,816,235.00
Balthasar, Dr. Joseph Center for Protein Therapeutics Nonfederal Multiple Sponsors 01-Sep-2017 31-Aug-2022 7,349,501.70
Balthasar, Dr. Joseph Pharmacokinetic strategies to increase monoclonal antibody uptake, distribution, and efficacy for treatment of solid tumors Federal National Cancer Institute 01-Jun-2020 31-May-2025 1,814,481.00
Balthasar, Dr. Joseph Enhancement of ADC selectivity by inverse targeting: Mechanistic studies and optimization Federal National Cancer Institute 01-Jun-2021 31-May-2026 1,824,363.00
Balu-Iyer, Dr. Sathy V Tolerance Inducing Phosphatidylserine (TIPS): a nanoparticle-based platform for immunotherapy Nonfederal Empire Discovery Institute 13-May-2021 13-May-2022 102,480.00
Balu-Iyer, Dr. Sathy V Development of Lipid Based Platform for Nucleic Acid Delivery Nonfederal University of Rochester 01-Apr-2021 30-Sep-2021 20,000.00
Bednarczyk, Dr. Edward M C19: Chronic Disease Medication Utilization and the Novel Coronavirus Disease 2019 (COVID-19) Infection Nonfederal American College of Clinical Pharmacy 01-Jan-2021 31-Dec-2021 600.00
Bednarczyk, Dr. Edward M NYS Prescription Monitoring CE Program Federal Flow Through Island Peer Review Organization 01-Sep-2021 31-Oct-2022 12,632.00
Bies, Dr. Robert R. Physiologically-based model of the female reproductive tract: vaginal and intrauterine delivery components- Support New Approaches to Improve Product Manufacturing and Quality Federal US Food and Drug Administration 26-Sep-2018 25-Jan-2024 940,749.00
Bies, Dr. Robert R. Film Antiretroviral Microbicide Evaluation Federal Flow Through Magee-Womens Research Institute and Foundation 01-Jun-2019 31-May-2022 405,130.00
Bies, Dr. Robert R. Pharmacokinetics of sedatives - Understanding a modifiable risk factor for pediatric delirium Federal Flow Through Childrens Research Institute 01-Sep-2019 31-Jul-2024 30,566.00
Bies, Dr. Robert R. Long Acting Film Technology for Contraception and HIV Prevention (LATCH) Federal Flow Through Magee-Womens Research Institute and Foundation 01-Feb-2021 31-Jan-2022 40,060.00
Bies, Dr. Robert R. Evaluation of safety and pharmacokinetics of naltrexone implant Federal Flow Through Research Foundation for Mental Hygiene 01-Mar-2021 28-Feb-2022 70,875.00
Blanco, Dr. Javier Understanding the Molecular Underpinnings of Anthracycline-related Cardiomyopathy in Childhood Cancer Survivors Nonfederal Board of Trustees of the University of Alabama Birmingham 01-Feb-2019 31-Jan-2022 54,369.00
Blanco, Dr. Javier Evaluation of myocardial targets to prevent anthracycline cardiotoxicity in children with Down Syndrome and Leukemia Federal National Cancer Institute 23-Sep-2019 31-Aug-2022 438,625.00
Blanco, Dr. Javier The Who and Why of Anthracycline-related Cardiotoxicity in Childhood Cancer Survivors Nonfederal Board of Trustees of the University of Alabama Birmingham 01-Jul-2019 30-Jun-2022 37,238.00
Chilbert, Dr. Maya Rachael Comparison of Triple Theraply with Apixaban vs. Rivaroxaban Nonfederal American College of Clinical Pharmacy 01-Jul-2020 31-Dec-2021 4,000.00
Jacobs, Dr. David Matthew Impact of an Integrated Pharmacist and Primary Care Collaborative Transitions of Care Program on Clinical and economic Outcomes among High Risk Patients Nonfederal ASHP Research and Education Foundation 01-Jul-2019 30-Jun-2022 75,000.00
Jacobs, Dr. David Matthew Impact and feasibility of establishing a Community Health Worker Program within Community Pharmacy Settings Nonfederal Community Pharmacy Foundation 01-Jan-2020 01-Oct-2021 39,533.00
Jacobs, Dr. David Matthew A qualitative study to understand patient and social factors related to nebulizer use at the transition of care in COPD Nonfederal Mylan Incorporated 15-Nov-2019 01-Oct-2021 38,682.00
Jacobs, Dr. David Matthew Integrative Informatics Approach to Predict Readmissions and Improve Outcomes in COPD Federal National Heart Lung and Blood Institute 01-Apr-2021 31-Mar-2026 962,055.00
Jacobs, Dr. David Matthew Improving the Health of Americans through Prevention and Management of Diabetes and Heart Disease and Stroke Federal Flow Through Community Pharmacy Enhanced Services Network 30-Jun-2021 29-Jun-2022 45,000.00
Jusko, Dr. William J Mechanistic Pharmacokinetics and Pharmacodynamics Federal National Institute of General Medical Sciences 01-May-2019 30-Apr-2024 2,891,677.00
Jusko, Dr. William J Training Program in Pharmacokinetics and Pharmacodynamics Nonfederal GlaxoSmithKline 03-Feb-2021 02-Feb-2023 255,200.00
Krzyzanski, Dr. Wojciech Population PK Model of Indomethaicin in Preterm Infants Nonfederal Childrens Mercy Hospital 14-Nov-2019 13-Nov-2021 10,000.00
Ma, Dr. Qing Doravirine Cerebrospinal Fluid (CSF) Pharmacokinetics in HIV-Infected Individuals Nonfederal Merck Sharp and Dohme Corporation 04-Jun-2019 04-Jun-2022 142,500.01
Ma, Dr. Qing Aging, Polypharmacy and Neurotoxicity in Adults Living with HIV Federal National Institute on Aging 01-May-2020 28-Feb-2025 4,006,139.00
Ma, Dr. Qing Bictegravir in the Elderly Living with HIV: Impact of Polypharmacy and Multimorbidity Nonfederal Gilead Sciences Incorporated 01-Oct-2019 29-Sep-2022 67,270.00
Mager, Dr. Donald E Immunologic and Neurodevelopmental Consequences of Neonatal Anemia and Thrombocytopenia and their Treatments Federal Flow Through Childrens Hospital of Boston 01-Sep-2018 30-Jun-2023 655,055.00
Mager, Dr. Donald E Optimizing GVHD Prevention with Systems Pharmacology Models Federal Flow Through Beckman Research Institute of the City of Hope 01-Jun-2019 31-May-2024 549,900.00
Mager, Dr. Donald E Mechanistic PKPD modelling of biologic treatments in lymphoid leukemia for better understanding of efficacy and safety Foreign Institut de Recherches Internationales Servier 01-Aug-2019 31-Jul-2022 227,090.00
Meaney, Dr. Calvin J. T Regulatory Cell Response to Erythropoiesis Stimulating Agents Post-Renal Transplantation Nonfederal American College of Clinical Pharmacy 01-Nov-2018 31-Oct-2021 5,000.00
Meaney, Dr. Calvin J. Optimizing Vancomycin Use and Clinical Outcomes in Hemodialysis Patients Nonfederal American College of Clinical Pharmacy 01-Jan-2021 31-Dec-2021 3,000.00
Morris, Dr. Marilyn E SBIR: Development of Novel PDE4B Inhibitors to Treat Alcohol Use Disorder Federal Flow Through Codex BioSolutions Incorporated 23-Sep-2019 22-Sep-2021 73,459.00
Morse, Dr. Gene University of Rochester HIV/AIDS Clinical Trials Unit Federal Flow Through University of Rochester 01-Dec-2013 30-Nov-2021 480,340.00
Morse, Dr. Gene Clinical Pharmacology Quality Assurance Federal National Institute of Allergy & Infectious Disease 30-May-2015 29-May-2022 10,516,782.70
Morse, Dr. Gene HIV Research Training Program Federal Fogarty International Center 01-Apr-2016 28-Feb-2022 1,884,534.00
Morse, Dr. Gene Global Infectious Diseases Research Training Program Federal Fogarty International Center 11-Apr-2018 28-Feb-2023 1,125,653.00
Morse, Dr. Gene ACTG Precautionary and Prohibited Medications Database Federal Flow Through Regents of the University of California Los Angeles 01-Dec-2020 30-Nov-2021 190,000.00
Morse, Dr. Gene ACTG Pharmacology Specialty Laboratory Federal Flow Through Regents of the University of California Los Angeles 01-Dec-2020 30-Nov-2027 1,953,875.00
Morse, Dr. Gene C19: WNY COVID-19 Research Collaborative Nonfederal John R Oishei Foundation 01-Jun-2021 31-Dec-2021 54,450.00
Morse, Dr. Gene A Pilot Study to Investigate the Pharmacokinetic Properties of single- and multi-dose administration of a commercially available full-spectrum hemp-based CBD extract in Healthy Volunteers Nonfederal Dent Neuroscience Research Center 11-Aug-2021 31-Dec-2021 63,468.00
Qu, Dr. Jun Modeling Mechanisms of Adjuvanted Influenza Vaccine Induced IgG Repertoire Diversity and Heterosubtypic Immunity URF (AWD00001405) Federal Flow Through University of Rochester 01-Feb-2017 31-Jan-2022 467,930.00
Qu, Dr. Jun GMPS-GMPR axis melanoma progression and therapy Federal Flow Through Wake Forest University Health Sciences 23-Nov-2018 30-Apr-2023 101,678.00
Qu, Dr. Jun Comprehensive characterization of upregulated proteases in diseased vs normal tissues Nonfederal AbbVie Incorporated 19-Jun-2019 31-Dec-2021 224,675.00
Qu, Dr. Jun Novel LC-MS strategies for comprehensive investigations of Circulating Immune Complext and MHC Presenting Peptides Nonfederal GlaxoSmithKline 08-Jul-2019 31-Jul-2022 434,493.00
Qu, Dr. Jun Neuroinflammation-related phosphoprotein signaling pathways as potential therapeutic targets for GWI using an established animal model Federal Flow Through West Virginia Univ. Research Corp. on behalf of West Virginia Univ. 01-Feb-2020 31-Jan-2022 103,669.00
Qu, Dr. Jun The Network Biology of Pathogen-Host Interactions Driving Exacerbation in Chronic Obstructive Pulmonary Disease (COPD) Federal Flow Through Buffalo Institute for Medical Research 15-Sep-2019 14-Sep-2022 335,351.00
Qu, Dr. Jun Highly sensitive multiplexed targeted mass spectrometric assays of proteins/peptides of significance in obesity research Federal Flow Through Pacific Northwest National Laboratory 19-Feb-2020 31-Jul-2023 618,520.00
Qu, Dr. Jun Extracellular Vesicle treatment and age-related neuropathology in non-human primates Federal Flow Through Trustees of Boston University 15-Sep-2020 30-Apr-2025 191,400.00
Qu, Dr. Jun Alternative Polyadenylation as a Novel Mediator of Therapeutic Resistance in Lung Cancer Federal Flow Through Health Research Inc 01-Jul-2021 30-Jun-2022 14,645.00
Ramanathan, Dr. Murali The Metabolomics-Neurofilaments-Neurodegeneration Nexus in Multiple Sclerosis Progression Federal US Army Medical Research Acquisition Activity 01-Jul-2020 30-Jun-2023 957,000.00
Shah, Dr. Dhavalkumar Development of a quantitative systems pharmacology (QSP) Model to Support Clinical Translation of adeno-associated virus (AAV) Vectorized Brain Delivery of Anti-a-Synuclein (AS) Antibody Foreign AstraZeneca UK Limited 13-Jul-2020 31-Jul-2022 252,800.00
Shah, Dr. Dhavalkumar C19: UB CAT: Big-Data and AI Driven De Novo Discovery of Novel Antibodies For COVID-19 Nonfederal Manhattan BioSolutions LLC 01-Jul-2021 30-Jun-2022 3,500.00
Shah, Dr. Dhavalkumar C19: UB CAT: Big-Data and AI Driven De Novo Discovery of Novel Antibodies For COVID-19 Nonfederal EVQLV 01-Jul-2021 30-Jun-2022 24,500.00
Straubinger, Dr. Robert M Tumor priming sequences combined with novel nanoparticle drug carriers for enhanced therapeutic efficacy in pancreatic cancer Federal National Cancer Institute 01-Jul-2015 31-Aug-2022 2,156,820.00
Straubinger, Dr. Robert M Large-scale proteome-wide analysis with high accuracy/precision to guide pancreatic cancer therapy development Federal National Cancer Institute 21-Dec-2018 30-Nov-2021 398,683.00
Tornatore, Dr. Kathleen M Age and Race Influences on Immunosuppression after Renal Transplant Federal National Institute on Aging 15-Aug-2018 30-Jun-2023 3,507,814.00
Tsuji, Dr. Brian T Novel Strategies for Antibiotic Combinations to Combat Gram-negative Superbugs Federal National Institute of Allergy & Infectious Disease 20-Dec-2019 30-Nov-2024 3,920,362.00
Tsuji, Dr. Brian T Exploitation of multiple heteroresistance for effective antibiotic combination therapy Federal Flow Through Emory University 01-Jul-2020 30-Jun-2022 202,832.00
Woo, Dr. Sukyung Overcoming Resistance to Anti-VEGF Therapy with Predictive Modeling Nonfederal American Cancer Society 09-Dec-2019 31-Dec-2021 298,793.66
Xu, Dr. Ying Preclinical Evaluation of Tetra Compounds in Mice Nonfederal Tetra Discovery Partners 18-Jan-2021 31-Jan-2022 188,791.00
Xu, Dr. Ying Role of PDE2A in mitochondrial dysfunction in Alzheimer's disease Federal National Institute on Aging 15-Aug-2021 30-Apr-2026 3,899,264.00
You, Dr. Young Jae Mechanistic studies of gamma-glutamyl transpeptidase inhibition: A novel approach to modulating serum levels of cysteine Federal Flow Through Board of Regents of the University of Oklahoma 01-Jan-2020 31-Aug-2022 121,218.00